One of AIMM’s earliest and most steadfast partners is Apexus, the non-profit contractor that works with more than 29,000 health care providers across the U.S. to lower their costs for purchasing outpatient pharmaceutical products, allowing them to stretch their resources to serve more low-income and uninsured patients. As the exclusive contractor for the 340B Drug Pricing Program, managed by the Health Resources and Service Administration (HRSA), Apexus negotiates significant discounts for branded and generic pharmaceuticals while working with providers to help them comply with 340B regulations and guidance. Apexus works closely with HRSA’s Office of Pharmacy Affairs to improve the integrity of the 340B program.
Apexus is a partner with AIMM and ASHP to offer the National A3 Collaborative. Apexus was an early supporter of the AIMM Collaborative, and the work originally initiated through the Patient Safety and Clinical Pharmacy Services Collaborative, by awarding team scholarships to organizations that are making a positive impact on high-risk patient populations. Apexus is supporting scholarship funding to cover partial participation fees for all organizations interested in being a part of the A3 Collaborative. For more information about Apexus, visit www.apexus.com and www.340Bpvp.com